Ascendis Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
Employees
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
Employees

ASND Key Statistics

Market cap
12.47B
Market cap12.47B
Price-Earnings ratio
-41.45
Price-Earnings ratio-41.45
Dividend yield
Dividend yield
Average volume
427.97K
Average volume427.97K
High today
$208.39
High today$208.39
Low today
$203.02
Low today$203.02
Open price
$205.91
Open price$205.91
Volume
289.40K
Volume289.40K
52 Week high
$216.45
52 Week high$216.45
52 Week low
$118.03
52 Week low$118.03

ASND News

Simply Wall St 1d
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone Deficiency

Ascendis Pharma (NasdaqGS:ASND) just announced that its SKYTROFA (TransCon hGH) is now broadly available in the United States, with expanded dosing options for...

Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation Following Expanded SKYTROFA Launch for Adult Growth Hormone Deficiency
Simply Wall St 4d
Did a Fatal Adverse Event Just Shift Ascendis Pharma's Yorvipath Investment Narrative?

In the past week, an FDA adverse event report disclosed the death of a patient who had been treated with Ascendis Pharma’s hypoparathyroidism drug, Yorvipath, i...

Did a Fatal Adverse Event Just Shift Ascendis Pharma's Yorvipath Investment Narrative?

Analyst ratings

100%

of 16 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.